P A Kalra

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Clinicopathological correlation in biopsy‐proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease

J R Wright, Ajay Duggal, R Thomas et al. · Nephrology Dialysis Transplantation · 2001 · 114 citations · Full text

Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease

P Laboi, H. Mamtora, P A Kalra · Nephrology Dialysis Transplantation · 2000 · 96 citations

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

The use of eGFR and ACR to predict decline in renal function in people with diabetes

Richard Hoefield, P A Kalra, Paul Baker et al. · Nephrology Dialysis Transplantation · 2010 · 81 citations · Full text